NASHVILLE, Tenn. & GREENWOOD VILLAGE, Colo.--(EON: Enhanced Online News)--The Physician Services business of Envision Healthcare Corporation (NYSE: EVHC) has further expanded its Women’s and Children’s Services specialty, and its footprint in Alabama, through the acquisition of Alabama Neonatal Medicine, P.C. The group’s four physicians exclusively cover the neonatology units at Jackson Hospital, Baptist Medical Center East and Baptist Medical Center South in the Montgomery, Alabama, area. This combination provides a complement to Envision’s existing neonatal programs in Huntsville, Mobile, and Dothan, Alabama.
Dr. Allen Newton, MD, President of Alabama Neonatal Medicine, commented, “We at Alabama Neonatal Medicine are excited about joining our efforts with Envision Healthcare. Our focus has always been on improving the healthcare of infants in central Alabama. Envision not only shares this goal, but will bring its unparalleled expertise and resources to this endeavor. Working together with the region’s hospitals and other medical providers, we will strive to enhance the healthcare experiences and outcomes of young children and their families throughout central Alabama.”
Robert J. Coward, President of Envision’s Physician Services business, noted, “We are excited to have been chosen by the physicians of Alabama Neonatal Medicine as their strategic partner in growing their practice and providing the necessary resources to thrive in a dynamic healthcare environment. At Envision, we are committed to the growth and development of each of our service lines, and this practice is a great addition to our Women’s and Children’s specialty.”
About Envision Healthcare Corporation
Envision Healthcare Corporation is a leading provider of physician-led services, ambulatory surgery center management, post-acute care and medical transportation. Physician-led services encompass providers at 780 hospitals in 45 states and include leadership positions in emergency department and hospitalist services, anesthesiology, radiology, and women’s / children’s services, as well as offerings in general surgery and office-based medicine. As a market leader in ambulatory surgical care, the company owns and operates 260 surgery centers and one surgical hospital in 35 states and the District of Columbia, with medical specialties ranging from gastroenterology to ophthalmology and orthopedics. Post-acute care is delivered through an array of clinical professionals and integrated technologies designed to contribute to efficient and effective population health management strategies. As a leader in healthcare transportation services, the company operates in 39 states and the District of Columbia. In total, the company offers a differentiated suite of clinical solutions on a national scale, creating value for health systems, payors, providers and patients. For additional information, visit www.evhc.net.
Certain statements and information in this communication may be deemed to be “forward-looking statements” within the meaning of the Federal Private Securities Litigation Reform Act of 1995. Forward-looking statements may include, but are not limited to, statements relating to Envision Healthcare Corporation’s (the “Company”) objectives, plans and strategies, and all statements (other than statements of historical facts) that address activities, events or developments that the Company intends, expects, projects, believes or anticipates will or may occur in the future. These statements are often characterized by terminology such as “believe,” “hope,” “may,” “anticipate,” “should,” “intend,” “plan,” “will,” “expect,” “estimate,” “project,” “positioned,” “strategy” and similar expressions, and are based on assumptions and assessments made by the Company’s management in light of their experience and their perception of historical trends, current conditions, expected future developments, and other factors they believe to be appropriate. Any forward-looking statements in this communication are made as of the date hereof, and the Company undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance. Whether actual results will conform to expectations and predictions is subject to known and unknown risks and uncertainties, including: (i) risks and uncertainties discussed in the reports that each of the Company, Envision and AMSURG have filed with the Securities and Exchange Commission; (ii) general economic, market, or business conditions; (iii) the impact of legislative or regulatory changes, such as changes to the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010; (iv) changes in governmental reimbursement programs; (v) decreases in revenue and profit margin under fee-for-service contracts due to changes in volume, payor mix and reimbursement rates; (vi) the loss of existing contracts; (vii) risks associated with the ability to successfully integrate the Company’s operations and employees following the merger; (viii) the ability to realize anticipated benefits and synergies of the business combination; and (ix) the potential impact of the consummation of the transaction on the Company’s relationships, including with employees, customers and competitors; and (x) other circumstances beyond the Company’s control. Refer to the section entitled “Risk Factors” in each of Envision’s and AMSURG’s annual and quarterly reports filed in 2016 for a discussion of important factors that could cause actual results, developments and business decisions to differ materially from forward-looking statements.